Results 211 to 220 of about 100,456 (311)
This study assessed the probiotic potential of intestinal microbiomes from five snake species using metagenomics and in vitro isolation, identifying two promising strains (Lactobacillus johnsonii DA0116 and Limosilactobacillus reuteri DA0218) through comprehensive screening.
Xuena Kang +11 more
wiley +1 more source
Gastric Lipoma in a 10‐Year‐Old Patient: A Case Report and Literature Review
Pediatric Discovery, EarlyView.
Yiwen Huang +6 more
wiley +1 more source
This study identified open‐type atrophic gastritis, flat or depressed morphology, faded appearance, tumor location on the greater curvature or anterior wall, xanthoma, and previous Helicobacter pylori eradication as independent risk factors for undifferentiated‐type‐predominant mixed‐type early gastric cancer (UM‐EGC).
Lin Lin Shao +4 more
wiley +1 more source
Complete blood count-derived inflammatory indices: A noninvasive aid for risk stratification in gastric ulcer. [PDF]
Kalkanli Tas S, Aydın F, Kirkik D.
europepmc +1 more source
The multicenter, prospective, non‐interventional, real‐world VIEW study of 2829 patients in China treated with vonoprazan found the treatment to be well tolerated, with 17.2% of patients reporting at least one adverse event. Among the 1796 patients with reflux esophagitis (RE), the proportion of those without gastroesophageal reflux disease increased ...
Ying Lian Xiao +8 more
wiley +1 more source
Balancing emergency repair and oncological safety in gastric ulcer perforations. [PDF]
Tuncer A, Kayaalp C.
europepmc +1 more source
This review provides the first comprehensive synthesis focused exclusively on hypermucinous dysplasia, summarizing its histopathologic definition, precursor lesions, clinicopathological associations, molecular features, and diagnostic reproducibility.
Ádám Ferenczi +2 more
wiley +1 more source
Bidirectional and mediation Mendelian randomization of dietary intake and risks of gastric ulcer and gastric cancer. [PDF]
Yang L +11 more
europepmc +1 more source
ABSTRACT Background Peptic ulcer disease (PUD) continues to be a health issue, mainly due to Helicobacter pylori (H. pylori) infection and non‐steroidal anti‐inflammatory drugs (NSAIDs). Despite better treatment of H. pylori and use of proton pump inhibitors, the rate of reduction in PUD complications is slowing down.
Vidya Willis +3 more
wiley +1 more source

